Pure Bioscience, Inc. (PURE) Reports Q2 Loss of $0.05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.07 -12.5%
Financial Fact:
Research and development: 248K
Today's EPS Names:
SICP, MNSB, CFFI, More
Financial Fact:
Research and development: 248K
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Pure Bioscience, Inc. (NASDAQ: PURE) reported Q2 EPS of ($0.05), versus ($0.07) reported last year. Revenue for the quarter came in at $221 thousand, versus $68 thousand reported last year.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scotiabank Names Top Utility Stocks Amid Data Center Growth
- StoneX Reiterates Hold Rating on Meta Platforms Inc. (META) as Strategy Lacks Quantified Returns, Product Economics
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
